GlassScriptPhysician profile
Jonathan Flescher
NPI 1558356618
$675.04
in general payments reported to CMS, 2019-2025
14 companies · $87.10 in 2025
The $87.10 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $51.49 · 2021: $12.54 · 2022: $132 · 2023: $26.06 · 2024: $141 · 2025: $87.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $176.27 | 2021-2025 | Eterna, Freestyle Libre 3, Proclaim |
| Janssen Pharmaceuticals, INC | $135.21 | 2019-2020 | |
| Amgen INC. | $79.97 | 2019-2024 | Evenity |
| Pfizer INC. | $63.02 | 2019-2022 | |
| Daiichi Sankyo INC. | $35.53 | 2019-2024 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $35.02 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.23 | 2019-2022 | |
| Boston Scientific Corporation | $24.58 | 2022 | |
| Novo Nordisk INC | $21.55 | 2024 | Rybelsus, Ozempic |
| Philips North America LLC | $15.72 | 2022 | |
| Phadia US INC. | $15.45 | 2024 | Immunocap |
| Amarin Pharma, INC. | $15.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.73 | 2022 | |
| Sonex Health, INC. | $11.52 | 2023 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Flescher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.